European Medical Journal Neurology (Aug 2024)
Bromocriptine in the Management of Central Hyperthermia
Abstract
Central fever, or hyperthermia of central origin, is a not so rare cause of hyperthermia in neurological rehabilitation units, characterised by persistent fever without any recognisable cause, and poor response to conventional antipyretics. This article reports a case of central fever in a patient with tuberculous meningitis, treated with dopamine agonist bromocriptine in conventional doses, which resulted in fever remission. The current literature is also reviewed.